(Q34500886)

2 August 2017

title

In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness (English)

1 reference

2 August 2017

0 references

0 references

African trypanosomiasis

0 references

5

Victor Kande

0 references

Séverine Blesson

object named as

Severine Blesson

14

0 references

Andrea Kuemmerle

object named as

Andrea Kuemmerle

2

0 references

Johannes A Blum

3

object named as

Johannes Blum

1 reference

2 August 2017

1

Caecilia Schmid

1 reference

2 August 2017

Salah Ghabri

4

1 reference

2 August 2017

Victor Kande

5

1 reference

2 August 2017

Wilfried Mutombo

6

1 reference

2 August 2017

Medard Ilunga

7

1 reference

2 August 2017

Ismael Lumpungu

8

1 reference

2 August 2017

Sylvain Mutanda

9

1 reference

2 August 2017

Pathou Nganzobo

10

1 reference

2 August 2017

Digas Tete

11

1 reference

2 August 2017

Nono Mubwa

12

1 reference

2 August 2017

Mays Kisala

13

1 reference

2 August 2017

Olaf Valverde Mordt

15

1 reference

2 August 2017

language of work or name

English

0 references

publication date

29 November 2012

1 reference

PLoS Neglected Tropical Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

6

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

e1920

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

copyright license

start time

29 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Clinical aspects of 2541 patients with second stage human African trypanosomiasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

The situation of sleeping sickness in Angola: a calamity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3510081

10.1371/JOURNAL.PNTD.0001920

7 July 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference